| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(01)00088-3 |
| P698 | PubMed publication ID | 11395211 |
| P2093 | author name string | J D Clements | |
| M J McCluskie | |||
| H L Davis | |||
| R D Weeratna | |||
| P2860 | cites work | CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma | Q24568172 |
| CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice | Q33597242 | ||
| Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes | Q33784161 | ||
| Immunization against hepatitis B virus by mucosal administration of antigen-antibody complexes | Q33857473 | ||
| Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract | Q34003245 | ||
| CpG motifs in bacterial DNA trigger direct B-cell activation | Q34307394 | ||
| Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity | Q36377098 | ||
| A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity | Q36770993 | ||
| Effective immunity to dental caries: enhancement of salivary anti-Streptococcus mutans antibody responses with oral adjuvants | Q37111929 | ||
| Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine. | Q39570111 | ||
| Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems | Q40788029 | ||
| Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen. | Q40790811 | ||
| TH2-type cytokines in asthma | Q41200649 | ||
| Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen | Q45753076 | ||
| CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus | Q45754574 | ||
| Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus | Q45768651 | ||
| Immunostimulatory DNA is a potent mucosal adjuvant | Q46476023 | ||
| Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin | Q48026935 | ||
| LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp. | Q50131343 | ||
| Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. | Q54627789 | ||
| Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. | Q54636789 | ||
| CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma☆☆☆★ | Q60147719 | ||
| The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity | Q67542118 | ||
| Oral adjuvants enhance IgA responses to Streptococcus mutans | Q70303200 | ||
| Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha | Q70866576 | ||
| Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin | Q71643281 | ||
| The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT) | Q73028927 | ||
| CpG DNA as mucosal adjuvant | Q73042328 | ||
| Regulation of T-helper type 2 cell and airway eosinophilia by transmucosal coadministration of antigen and oligodeoxynucleotides containing CpG motifs | Q73407815 | ||
| CpG DNA induces stronger immune responses with less toxicity than other adjuvants | Q73502903 | ||
| Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12 | Q73561535 | ||
| Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21 | Q74401213 | ||
| Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin | Q74494513 | ||
| Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid | Q74586086 | ||
| Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit | Q77132335 | ||
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 3759-3768 | |
| P577 | publication date | 2001-06-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants | |
| P478 | volume | 19 |
| Q33768109 | Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins |
| Q35585084 | CpG DNA: Trigger of Sepsis, Mediator of Protection, or Both? |
| Q37521856 | CpG adjuvant enhances the mucosal immunogenicity and efficacy of a Treponema pallidum DNA vaccine in rabbits |
| Q79847034 | CpG oligodeoxynucleotides and mobilization of innate mucosal immunity: tasks and tactics |
| Q57804907 | Crude saponins improve the immune response to an oral plant-made measles vaccine |
| Q41459314 | Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens |
| Q74765096 | Enhancement of rat tear IgA antibody responses following intranasal immunization with antigen and CpG ODN |
| Q35671658 | Immunization with Heat Shock Protein A and γ-Glutamyl Transpeptidase Induces Reduction on the Helicobacter pylori Colonization in Mice |
| Q54492375 | Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24Gag. |
| Q28744570 | Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection |
| Q40684882 | Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants |
| Q34572139 | Man the barrier! Strategic defences in the intestinal mucosa |
| Q33715999 | Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities |
| Q36055990 | Mucosal adjuvants |
| Q36517179 | Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity |
| Q44826911 | Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii |
| Q77526036 | Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine |
| Q35689341 | Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants. |
| Q30394326 | Needle-free influenza vaccination. |
| Q37810816 | Progress towards a needle-free hepatitis B vaccine |
| Q33946563 | Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. |
| Q44395938 | Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. |
| Q34533990 | Robust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coli |
| Q35011950 | Study of capsular polysaccharide from Vibrio parahaemolyticus |
| Q35867213 | Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice |
Search more.